Prostate Cancer

A Randomized, Double-Blind, Placebo-Controlled Phase III Study of Early versus Standard Zoledronic Acid to Prevent Skeletal-Related Events in Men with Prostate Cancer Metastatic to Bone [CALGB 90202]

Principal Investigator:
James Hannigan, M.D.
Adventist La Grange Hospital
(708) 579-3418
Contact: Terri Crestani, MPH 

CHAARTED: Chemo-Hormonal Therapy vs. Androgen Ablation Randomized Trial for Extensive Disease Prostate Cancer [ECOG 3805]

Principal Investigator:
Elyse Schneiderman, M.D.
Adventist Hinsdale Hospital
(630) 654-1790
Contact: Jan Wilson, R.N.

Phase II Trial of E7389 (Halichondrin B Analog) in Patients with Metastatic Hormone Refractory Prostate Cancer [ECOG 5805]

Principal Investigator:
Elyse Schneiderman, M.D.
Adventist Hinsdale Hospital
(630) 654-1790
Contact: Jan Wilson, R.N.